Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06555952 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors

Study acronym: GSEBP
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Jul 22, 2026 → Jul 22, 2027
See other at-risk trials from Clinical Nutrition Research Center, Illinois Institute of Technology

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jul 22, 2026 to Jul 22, 2027
    • Study completion pushed from Dec 31, 2026 to Dec 31, 2027
    v5
  2. Primary completion date: May 22, 2025 to Jul 22, 2026
    • Study completion date: May 22, 2025 to Dec 31, 2026
    v4
  3. Interventions: MegaNatural-BP SR 150Mg Tablet (Drug), Placebo Capsule (Other) to MegaNatural-BP SR 150Mg Tablet (Dietary Supplement), Placebo Capsule (Other)v3
  4. Primary endpoints: 1 to 2
    • Study description expanded, about 2 words
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Inflammation and stressors can interfere with the function of the lining of blood vessels and insulin activity, therefore, investigators are aiming to see how the Grape seed Extract (GSE) called MegaNatural BP can help with limiting the effects of these factors. This research will study the effects of taking 150mg of MegaNatural BP GSE per day on blood pressure levels along with influences on heart health through assessing the function of the blood vessel lining and levels of inflammation.
Trial Details
NCT Number NCT06555952
Lead Sponsor Clinical Nutrition Research Center, Illinois Institute of Technology
Conditions
(from sponsor)		 Hypertension, Pre Diabetes
Related terms Glucose Intolerance, Hypertension
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov